{
    "2018-08-16": [
        [
            {
                "time": "",
                "original_text": "抓茅台擒恒瑞 这家明星QFII二季度大举买入了这只股票",
                "features": {
                    "keywords": [
                        "QFII",
                        "恒瑞",
                        "买入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞第四个创新药来了！市场规模30亿",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "创新药",
                        "市场规模"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "直面挑战，勇往直前 国产新药和仿制药再迎突破",
                "features": {
                    "keywords": [
                        "国产新药",
                        "仿制药",
                        "突破"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "347亿资金争夺20股：主力资金重点出击6股(名单)",
                "features": {
                    "keywords": [
                        "资金",
                        "主力",
                        "出击"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【读懂中报】两大维度看透恒瑞医药 警惕成为下一个“辉瑞制药”",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "中报",
                        "警惕"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报:国家医保局,14种抗癌药将迎来新一轮降价",
                "features": {
                    "keywords": [
                        "国家医保局",
                        "抗癌药",
                        "降价"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]医药生物行业动态：上海带量采购分析 集中招采促进行业升级",
                "features": {
                    "keywords": [
                        "买入评级",
                        "医药生物",
                        "带量采购",
                        "行业升级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]恒瑞医药(600276)点评：吡咯替尼审评完毕 有望快速放量推动业绩高速增长",
                "features": {
                    "keywords": [
                        "买入评级",
                        "恒瑞医药",
                        "吡咯替尼",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【东吴晨报0816】【行业】房地产【个股】先导智能、我武生物、赢时胜、国祯环保等",
                "features": {
                    "keywords": [
                        "东吴晨报",
                        "房地产",
                        "个股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "房地产",
                        "医药",
                        "科技",
                        "环保"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}